C-H. Chiu

LBA8 Nivolumab (NIVO) + chemotherapy (chemo) vs chemo in patients (pts) with EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) with disease progression after EGFR tyrosine kinase inhibitors (TKIs) in CheckMate 722

Tony Mok, K. Nakagawa, K. Park et al. · Annals of Oncology · 2022 · 49 citations · Full text

Medicine, Oncology, Pharmacology +14

1325P Sunvozertinib as first-line treatment in NSCLC patients with EGFR Exon20 insertion mutations

James Chih‐Hsin Yang, M. Wang, C-H. Chiu et al. · Annals of Oncology · 2023 · 12 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

364O Intracranial efficacy of entrectinib in patients with NTRK fusion-positive solid tumours and baseline CNS metastases

Thomas John, C-H. Chiu, B.C. Cho et al. · Annals of Oncology · 2020 · 11 citations

Medicine, Neurology, Oncology +16

1208P Final results of APOLLO study: Overall survival (OS) of aumolertinib in patients with pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (NSCLC)

Shun Lu, Q. Wang, G. Zhang et al. · Annals of Oncology · 2021 · 10 citations

Medicine, Oncology, Pharmacology +16